Internal Server Error

Panacea - About the company

Panacea is a series E company based in Kolar (India), founded in 1999 by Raghu Padmanabhan and Gvs Manyam. It operates as a Developer of devices for radiotherapy. Panacea has raised $16.5M in funding from investors like New Enterprise Associates, Tara Fund and Claypond Capital, with a current valuation of ₹*****. The company has 15 active competitors, including 5 funded and 4 that have exited. Its top competitors include companies like BetaGlue Technologies, Viewraysystems and Kallisio.

Company Details

Developer of devices for radiotherapy. The product Bhabhatron MLC and Bhabhatron 3 are gamma therapy units, Imagin is an advanced radiotherapy simulator, Siddharth II has stereotactic Imaging, and Impact for immobilization and patient positioning. The company also has mammography units which include Lilac 2DC, Lilac 2DD, and Lilac.
Social
XFacebook
Email ID
*****@panaceamedical.com
Phone Number
+91 **********
Registered Address
Plot No.35 4th Phase, KIADB Industrial Area, Kolar, Malur, Karnataka, India, 563130
Key Metrics
Founded Year
1999
Location
Kolar, India
Stage
Series E
Total Funding
$16.5M in 10 rounds
Post Money Valuation
₹***** as on Nov 11, 2025
Ranked
Annual Revenue
₹50 - ₹100 Cr as on Mar 31, 2025
Employee Count
361 as on Aug 31, 2025
Similar Companies
Sign up to download Panacea's company profile

Panacea's funding and investors

Panacea has raised a total funding of $16.5M over 10 rounds. Its first funding round was on Dec 27, 2013. Its latest funding round was a Conventional Debt round on Oct 19, 2026 for $*****. 2 investors participated in its latest round. Panacea has 5 institutional investors and 10 angel investors.

Here is the list of recent funding rounds of Panacea:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Oct 19, 2026
7244194
Conventional Debt
3079981
7979738
3147276
8450197
Nov 11, 2025
3410991
Series E
8761974
5334438
6138605
Jan 02, 2025
2815597
Series D
8060277
9773561
3406289
lockAccess funding benchmarks and valuations. Sign up today!

Panacea's founders and board of directors

Founder? Claim Profile
The founders of Panacea are Raghu Padmanabhan and Gvs Manyam. Raghu Padmanabhan is the CEO of Panacea.
Here are the details of Panacea's key team members:

Panacea's Board of Directors

Panacea's board has 6 active members. Tarun Sharma, Charles Antoine Antoine Janssen, Bala C Deshpande, Satyalakshmi Goteti, Ramann Yerramilli and Nagavalli Goteti are independent board members.
Here is the list of Panacea's board of directors:
Name
Type
Representing
Status
Duration
Independent board member
-
Current
10y 11m
pvslhog
Independent board member
-
Current
6y 2m
ywplkhz
Independent board member
-
Current
5y 5m
ihakhal
Independent board member
-
Current
4y 1m
lezggsm
Independent board member
-
Current
2y 1m
lrkouzn
Independent board member
-
Current
3y 3m

Panacea's employee count trend

Panacea has 361 employees as of Aug 25. The total employee count is 6.0% more than what it was in Aug 24. Here is Panacea's employee count trend over the years:
Employee count trend for Panacea
lockUncover Panacea's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Panacea's Competitors and alternates

Top competitors of Panacea include BetaGlue Technologies, Viewraysystems and Kallisio. Here is the list of Top 10 competitors of Panacea, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for BetaGlue Technologies
BetaGlue Technologies
2017, Milano (Italy), Series A
Provider of a radiotherapy platform for the treatment of solid tumors
$18.9M
54/100
2nd
Logo for Viewraysystems
Viewraysystems
2004, Lage (Germany), Public
Manufacturer of MRI-guided radiation therapy systems for cancer treatment
$177M
51/100
3rd
Logo for Panacea
Panacea
1999, Kolar (India), Series E
Developer of devices for radiotherapy
$16.5M
49/100
4th
Logo for Kallisio
Kallisio
2022, Baltimore (United States), Unfunded
Developer of 3D printed oral stents for head and neck cancer patients
-
-
41/100
5th
Logo for EMulate Therapeutics
EMulate Therapeutics
2002, Seattle (United States), Public
Developer of radiofrequency based devices for treatment of cancers
$23.2M
-
39/100
6th
Logo for RITA Medical Systems
RITA Medical Systems
1994, Fremont (United States), Acquired
Products for oncology therapy
-
33/100
7th
Logo for Innoblative Designs
Innoblative Designs
2013, Chicago (United States), Seed
Developer of electrosurgical devices for multiple surgical procedures
$3.26M
30/100
8th
Logo for THERYQ
THERYQ
2022, Peynier (France), Unfunded
Developer of radiotherapy machines for cancer treatment
-
-
29/100
9th
Logo for Medsphere
Medsphere
2002, Shanghai (China), Series A
Developer of radiofrequency ablation and minimally invasive electrosurgical medical devices
-
29/100
10th
Logo for Ehmet Health
Ehmet Health
2015, Plymouth (United States), Seed
Developer of radiotherapeutic devices for treating breast cancer
$150K
-
28/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Panacea's competitors? Click here to see the top ones

Panacea's Latest cap tables and shareholding

Founders own 21.13%, Funds (largest shareholder) own 38.40%, Enterprises own 13.19% and Other People own 21.80%. The net worth of Panacea's founders is INR 142Cr as of Nov 11, 2025. The cap table displayed below is for PANACEA MEDICAL TECHNOLOGIES PRIVATE LIMITED which is the legal entity associated with Panacea.
Shareholders Name
Post Round Holding %
Net worth
Cumulative Investment
Realised Returns
Unrealised Returns
Return Multiple
Founder
21.13%
142Cr
4693687
3424948
6869413
8867358
4404796
2996262
4540268
2798005
3981540
2626713
Fund
38.40%
258Cr
4930001
7494280
5885939
7162400
Enterprise
13.19%
88.7Cr
8892771
2433071
8411289
7212332
Other People
21.80%
147Cr
7884775
8600662
5022101
7470816
ESOP Pool
5.48%
36.9Cr
39653
71950
16330
50823
Total
100.00%
672Cr
8990978
7749797
5025786
3504431
Notes: The column Net Worth represents the net worth of investments made by that entity, as per the latest cap table.
Disclaimer
Gain deeper insights into
shareholding pattern of this entity
$9.99$4.23(excl. taxes)
Download Sample Files
What documents will you get?
  • Latest Shareholding Summary - Ownership breakdown across founders, investors, and other stakeholders
  • Round-by-Round Cap Tables - Evolution of shareholding across funding rounds
  • Year-on-Year Cap Tables - Dilution trends over time

Panacea's Investments and acquisitions

Panacea has made no investments or acquisitions yet.

Reports related to Panacea

Here is the latest report on Panacea's sector:

News related to Panacea

lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Panacea

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford